The 1^st Regional Expert Meeting Paxus PM to be held in Seoul, South Korea where traditional cultures blend with modern life & high technology harmoniously on March 11- 14, 2009.

This scientific meeting, which is based on the theme of " First Regional Expert Meeting Paxus PM ", is just one of our initiatives to advance the frontiers of knowledge in new product technology development and further promote the message of improvement effectivity and reduce some adverse reaction.

As we have noticed during the past two decades, the taxanes have been utilized in the treatment of many types of cancer. Although they have demonstrated efficacy, toxicities associated with taxane treatment remain. This dilemmatic circumstance encourages many Pharmaceutical companies in the World to conduct research and develop an advanced formulations of taxanes that may improve both anti tumor activity and reduce toxicity.

One of these , Samyang Corporation, an Korea Pharmaceutical company, a very important strategic alliance of Kalbe has developed new drug delivery technology which may provide solution for Oncologist in treating patient with taxane more confidently.

Some beneficials in pharmacology aspect for using Paxus PM with Cremophor-free- Polymeric Micelle formulation technology of Paclitaxel give on improving solubility, avoid Cremophor usage with reducing hypersensitivity and toxicity, high dosabilibility with improving efficacy and high tumor concentration of drug.

Some doctor's and pharmacists delegating came from some countries, Philippines, Malaysia and Vietnam followed and participated on this sharing experience session at first REM Paxus PM , other delegate were also from Korea experts. Kalbe International, Pte, Ltd and Samyang corporation as a host of this event.